1. Market Research
  2. > Becton-Dickinson Medical Device Company Intelligence Report

Becton-Dickinson Medical Device Company Intelligence Report

  • May 2013
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Becton, Dickinson and Company (BD) is engaged principally in the manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. Its operations consist of three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences.

BD Medical produces a portfolio of medical devices that are used in a wide range of healthcare settings. They include safety-engineered injection, infusion and surgery products. BD Medical’s principal product lines include needles, syringes and intravenous (IV) catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self injection of insulin and other drugs used in the treatment of diabetes; prefillable drug delivery devices provided to pharmaceutical companies and sold to end-users as drug/device combinations; regional anaesthesia needles and trays; sharps disposal containers; and home healthcare products. The primary markets served by BD Medical are hospitals and clinics; physicians’ office practices; consumers and retail pharmacies; public health agencies; pharmaceutical companies; and healthcare workers.
BD Diagnostics provides products for the collection and transport of diagnostic specimens and instrumentation for analysis across a broad range of infectious disease testing, including healthcare-associated infections (HAIs). BD Diagnostics’ principal products and services include integrated systems for specimen collection; safety-engineered collection products and systems; plated media; automated blood culturing systems; molecular testing systems for sexually-transmitted diseases and HAIs; micro-organism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screenings; and rapid diagnostic assays. BD Diagnostics serves hospitals, laboratories and clinics; reference laboratories; blood banks; healthcare workers; patients; physicians’ office practices; and industrial microbiology laboratories.
BD Biosciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases. BD Biosciences’ principal product lines include fluorescence activated cell sorters and analysers; cell imaging systems, monoclonal antibodies and kits for performing cell analysis; reagent systems for life sciences research; tools to aid in drug discovery and growth of tissue and cells; cell culture media supplements for biopharmaceutical manufacturing; and diagnostic assays. The primary markets served by BD Biosciences are research and clinical laboratories; hospitals and transplant centres; blood banks; and biotechnology and pharmaceutical companies.
BD’s products are manufactured and sold worldwide. The company has manufacturing operations outside the US in Brazil, Canada, China, France, Germany, Hungary, India, Ireland, Japan, Mexico, Pakistan, Singapore, South Korea, Spain, Sweden and the UK.

The BD Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.

Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.

Key Benefits

Evaluate competitive threats
Maximise product and market opportunities
Identify collaborators and strategic partners
Understand the operating market environment
Benchmark your performance against competitors
Coverage Overview

Key contact information
Introduction to BD and its current activities
Summary of its financial performance
Key recent events in an “at a glance” format
Strategic Focus

The company’s aims and its areas of focus
Financial Review

Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Product Overview

Core product areas, key brands, product approvals and launches
Identifies the company’s major competitors
Research and Development

How much has been invested in R&D?
Where is the research based?
What alliances and agreements does BD have and with whom?
Manufacturing and Distribution

Identifying the company’s manufacturing locations
Sales and marketing facilities

With whom has BD reached agreements and what do they involve?
Key contracts awarded
Mergers and Acquisitions
Minority Divestments
Key Corporate Events

Table Of Contents

Becton-Dickinson Medical Device Company Intelligence Report
Espicom View 4
Fiscal Year 2012 Financial Results 5
BD Medical 8
BD Diagnostics 8
Biosciences Segment 9
Five-Year Financial Data 10
Outlook 11
Employees 11
BD Medical 12
Medical Surgical Systems 13
Pharmaceutical Systems 14
Diabetes Care 14
BD Medical Product Updates 14
BD Diagnostics 16
Preanalytical Systems 17
Diagnostic Systems 17
BD Diagnostics - TriPath Products 17
BD Diagnostics - Infectious Disease 17
BD Diagnostic Product Updates 18
Research Establishments 20
RandD Expenditure 20
RandD Projects 20
BD Max Development 20
Juvenile Diabetes Research Foundation 20
Manufacturing 22
Distribution 22
Asuragen 23
Biodiversity 24
Lab21 24
Diagenode 24
Cato Software Solutions 25
Safety Syringes 25
Kiestra Lab Automation 25
Carmel Pharma 25
Discovery Labware Unit 26
Hologic 27
Retractable Technologies 27

List of Tables

Recent Key Events 3
Fiscal Year 2012 Financial Results 5
BD - Annual Financial Results, 2008-2012 5
BD - Annual Revenues by Business Segment and Geographic Area, 2009-2012 6
BD - Annual Revenues and Operating Income by Business Segment, 2008-2012 7
BD Medical - Annual Revenue by Unit and Geographic Area, 2009-2012 8
BD Diagnostics - Annual Revenue by Unit and Geographic Area, 2009-2012 8
BD Biosciences - Annual Revenue by Unit and Geographic Area, 2009-2012 9
BD - Five-Year Financial Summary 10
BD Employees, 2008-2012 11
Medical Surgical Systems Key Product Areas 13
Preanalytical Systems Key Product Areas 17
BD Diagnostics - Planned Product Launches 19
BD - RandD Expenses, 2008-2012 20
Agreements Summary 23
Mergers and Acquisitions Summary 25

List of Charts

BD - Annual Sales and Operating Income, 2008-2012 5
BD - Annual Revenues by Geographic Area, 2009-2012 6
BD- Annual Sales by Business Segment, 2008-2012 7
BD Medical - Annual Sales by Product Area, 2009-2012 13
BD Diagnostics - Annual Sales by Product Area, 2009-2012 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.